ASH News Daily 2017 - Issue 1 - C-9
Saturday, December 9, 2017
ASH News Daily
Page C-9
®
Exhibitor List
«« From Page C-8
Rare Disease Therapeutics, Inc..................... 2560
Repertoire Genesis, Inc. ................................... 417
Resonance Health Ltd. .................................. 1450
Rigel Pharmaceuticals ................................... 2705
Roswell Park Cancer Institute ...................... 2045
S-T
Sandoz, A Novartis Company ...................... 1902
Sanofi Genzyme.............................................. 1340
Sanofi Genzyme.............................................. 1541
Sarah Cannon Research Institute ..................... 39
Save One Life, Inc........................................... 1662
Seattle Cancer Care Alliance ......................... 1940
Seattle Children's Hospital ........................... 1946
Seattle Genetics ............................................... 1301
Shands Teaching Hospital and Clinics, Inc. ...1746
Shire.................................................................. 2247
Shwachman-Diamond Syndrome
Foundation (SDSF) ...................................... 2050
SITC .................................................................. 1948
SkylineDx ........................................................ 2047
SoutheastHEALTH ........................................ 1660
Spectrum Pharmaceuticals, Inc. ..................... 423
Springer Healthcare ......................................... 409
Springer Nature .................................................. 49
St. Baldrick's Foundation .............................. 1750
STEMCELL Technologies, Inc. ....................... 941
StemExpress, LLC .......................................... 2952
Stemline Therapeutics ................................... 3122
Stemline Therapeutics ................................... 3143
Studio ER Congressi s.r.l. .................................611
Sunesis Pharmaceuticals, Inc. ....................... 2413
Synthego .......................................................... 2153
Takeda Oncology............................................ 2014
Takeda Oncology............................................ 2768
Takeda Oncology............................................ 3005
Techcyte, Inc. ..................................................... 504
Tecnofarma S.A................................................. 923
Tempus .............................................................. 408
TerSera Therapeutics ....................................... 313
TESARO........................................................... 2417
Teva Oncology ................................................ 1619
TG Therapeutics, Inc........................................ 905
The Aflac Cancer Center at
Children's Healthcare of Atlanta .............. 1852
The Binding Site, Inc. ..................................... 1833
The Blood and Marrow Transplant
Program at Northside Hospital..................... 43
The Guider Group .......................................... 2601
The JAMA Network ......................................... 608
The Japanese Society of Hematology .......... 1648
The Leukemia & Lymphoma Society .......... 1950
The Lynx Group ............................................. 1503
The Mastocytosis Society .............................. 1951
Tolero Pharmaceuticals, Inc. ........................... 503
Turkish Society of Hematology .................... 1841
Veristat ............................................................. 3247
Waldenstrom's Macroblobulinemia
Foundation ................................................... 1754
Winship Cancer Institute of
Emory University ........................................ 2053
WizSolution Research .................................... 1549
Wolters Kluwer ............................................... 1312
World Health Organization Press .................. 404
World Myeloma Forum ................................... 513
WVU Medicine ............................................... 1561
- As of November 9, 2017
Download the
official ASH® Annual
Meeting App
Have information
Download
the official
at
your
finger tips
ASH Annual Meeting App
®
Have information at your finger tips
U-V-W
UF Health Cancer Center - University
of Florida ...................................................... 1748
uniQure, Inc. ................................................... 2600
University of Chicago
Comprehensive Cancer Center ................. 2142
UT MD Anderson Cancer Center ................ 1507
Verastem .......................................................... 3043
Find it on
Google
Play or
the App
Store
Access valuable meeting information and resources, including the
full program schedule, slides from presentations, vital CME/MOC
information, speakers' bios, and more.
Find it on Google Play or the App Store
American Society of Hematology
Helping hematologists conquer blood diseases worldwide.
ASH AND 2017 Ads JUNIOR 7x10 REV.indd 2
11/3/17 10:53 AM
...and we're exploring multiple
immunotherapies to fight them.
We are shaping the future of immuno-oncology by developing innovative
therapies that target multiple immune cell types for the treatment of
hematologic malignancies and solid tumors.
Please visit us at our booth or at www.researchoncology.com to learn
more about our immuno-oncology program.
Immunology Is In Our Blood
Table of Contents for the Digital Edition of ASH News Daily 2017 - Issue 1
ASH News Daily 2017 - Issue 1 - A-1
ASH News Daily 2017 - Issue 1 - A-2
ASH News Daily 2017 - Issue 1 - A-3
ASH News Daily 2017 - Issue 1 - A-4
ASH News Daily 2017 - Issue 1 - A-5
ASH News Daily 2017 - Issue 1 - A-6
ASH News Daily 2017 - Issue 1 - A-7
ASH News Daily 2017 - Issue 1 - A-8
ASH News Daily 2017 - Issue 1 - A-9
ASH News Daily 2017 - Issue 1 - A-10
ASH News Daily 2017 - Issue 1 - A-11
ASH News Daily 2017 - Issue 1 - A-12
ASH News Daily 2017 - Issue 1 - A-13
ASH News Daily 2017 - Issue 1 - A-14
ASH News Daily 2017 - Issue 1 - A-15
ASH News Daily 2017 - Issue 1 - A-16
ASH News Daily 2017 - Issue 1 - A-17
ASH News Daily 2017 - Issue 1 - A-18
ASH News Daily 2017 - Issue 1 - A-19
ASH News Daily 2017 - Issue 1 - A-20
ASH News Daily 2017 - Issue 1 - A-21
ASH News Daily 2017 - Issue 1 - A-22
ASH News Daily 2017 - Issue 1 - A-23
ASH News Daily 2017 - Issue 1 - A-24
ASH News Daily 2017 - Issue 1 - A-25
ASH News Daily 2017 - Issue 1 - A-26
ASH News Daily 2017 - Issue 1 - A-27
ASH News Daily 2017 - Issue 1 - A-28
ASH News Daily 2017 - Issue 1 - B-1
ASH News Daily 2017 - Issue 1 - B-2
ASH News Daily 2017 - Issue 1 - B-3
ASH News Daily 2017 - Issue 1 - B-4
ASH News Daily 2017 - Issue 1 - B-5
ASH News Daily 2017 - Issue 1 - B-6
ASH News Daily 2017 - Issue 1 - B-7
ASH News Daily 2017 - Issue 1 - B-8
ASH News Daily 2017 - Issue 1 - B-9
ASH News Daily 2017 - Issue 1 - B-10
ASH News Daily 2017 - Issue 1 - B-11
ASH News Daily 2017 - Issue 1 - B-12
ASH News Daily 2017 - Issue 1 - B-13
ASH News Daily 2017 - Issue 1 - B-14
ASH News Daily 2017 - Issue 1 - B-15
ASH News Daily 2017 - Issue 1 - B-16
ASH News Daily 2017 - Issue 1 - B-17
ASH News Daily 2017 - Issue 1 - B-18
ASH News Daily 2017 - Issue 1 - B-19
ASH News Daily 2017 - Issue 1 - B-20
ASH News Daily 2017 - Issue 1 - B-21
ASH News Daily 2017 - Issue 1 - B-22
ASH News Daily 2017 - Issue 1 - B-23
ASH News Daily 2017 - Issue 1 - B-24
ASH News Daily 2017 - Issue 1 - B-25
ASH News Daily 2017 - Issue 1 - B-26
ASH News Daily 2017 - Issue 1 - B-27
ASH News Daily 2017 - Issue 1 - B-30
ASH News Daily 2017 - Issue 1 - B-31
ASH News Daily 2017 - Issue 1 - B-32
ASH News Daily 2017 - Issue 1 - B-33
ASH News Daily 2017 - Issue 1 - B-34
ASH News Daily 2017 - Issue 1 - B-35
ASH News Daily 2017 - Issue 1 - B-36
ASH News Daily 2017 - Issue 1 - B-37
ASH News Daily 2017 - Issue 1 - B-38
ASH News Daily 2017 - Issue 1 - B-39
ASH News Daily 2017 - Issue 1 - B-40
ASH News Daily 2017 - Issue 1 - B-41
ASH News Daily 2017 - Issue 1 - B-42
ASH News Daily 2017 - Issue 1 - B-43
ASH News Daily 2017 - Issue 1 - B-44
ASH News Daily 2017 - Issue 1 - B-45
ASH News Daily 2017 - Issue 1 - B-46
ASH News Daily 2017 - Issue 1 - B-47
ASH News Daily 2017 - Issue 1 - B-48
ASH News Daily 2017 - Issue 1 - B-49
ASH News Daily 2017 - Issue 1 - B-50
ASH News Daily 2017 - Issue 1 - B-51
ASH News Daily 2017 - Issue 1 - B-52
ASH News Daily 2017 - Issue 1 - B-53
ASH News Daily 2017 - Issue 1 - B-54
ASH News Daily 2017 - Issue 1 - B-55
ASH News Daily 2017 - Issue 1 - B-56
ASH News Daily 2017 - Issue 1 - C-1
ASH News Daily 2017 - Issue 1 - C-2
ASH News Daily 2017 - Issue 1 - C-3
ASH News Daily 2017 - Issue 1 - C-4
ASH News Daily 2017 - Issue 1 - C-5
ASH News Daily 2017 - Issue 1 - C-6
ASH News Daily 2017 - Issue 1 - C-7
ASH News Daily 2017 - Issue 1 - C-8
ASH News Daily 2017 - Issue 1 - C-9
ASH News Daily 2017 - Issue 1 - C-10
ASH News Daily 2017 - Issue 1 - C-11
ASH News Daily 2017 - Issue 1 - C-12
ASH News Daily 2017 - Issue 1 - C-13
ASH News Daily 2017 - Issue 1 - C-14
ASH News Daily 2017 - Issue 1 - C-15
ASH News Daily 2017 - Issue 1 - C-16
ASH News Daily 2017 - Issue 1 - C-17
ASH News Daily 2017 - Issue 1 - C-18
ASH News Daily 2017 - Issue 1 - C-19
ASH News Daily 2017 - Issue 1 - C-20
ASH News Daily 2017 - Issue 1 - C-21
ASH News Daily 2017 - Issue 1 - C-22
ASH News Daily 2017 - Issue 1 - C-23
ASH News Daily 2017 - Issue 1 - C-24
ASH News Daily 2017 - Issue 1 - C-25
ASH News Daily 2017 - Issue 1 - C-26
ASH News Daily 2017 - Issue 1 - C-27
ASH News Daily 2017 - Issue 1 - C-28
ASH News Daily 2017 - Issue 1 - C-29
ASH News Daily 2017 - Issue 1 - C-30
ASH News Daily 2017 - Issue 1 - C-31
ASH News Daily 2017 - Issue 1 - C-32
https://www.nxtbookmedia.com